A number of studies have shown that IL-6 is a new target for the treatment of COVID-19, and IL-6 inhibitors have the potential to treat COVID-19 (Coomes and Haghbayan, 2020; Gubernatorova et al., 2020) (Tang et al., 2020b; Xu et al., 2020b). This evidence concerns the gene IL6 and COVID-19.